May 20, 2020 / 03:40PM GMT
Matthew Charles Taylor - UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices
Great. Good morning. My name is Matt Taylor. I'm the UBS U.S. medical supplies devices analyst, and welcome to the next session in our Global Healthcare Virtual Conference. And I'm joined here in the medtech track by management from Integra Lifesciences Holdings. On the line today, we have Carrie Anderson, the Chief Financial Officer; and Michael Beaulieu, who leads the Investor Relations function for Integra.
And today, we'll have a fireside chat session for about 40 minutes, covering a lot of the key topics. As always, if you want to ask a question or steer the conversation, e-mail me or send that through the webcast.
Questions and Answers:
Matthew Charles Taylor - UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & DevicesSo just to get us started, I'll ask one about some of the recent trends. Carrie, leading into the COVID disruption, it looked like your 1Q trends were nicely above
Trustpilot
